BIRZNIEKS GUNTHER (SVP, Business Development) sold 5.3% of their position (17.41K shares) of VANDA PHARMACEUTICALS INC. on the open market
Open‑market sale worth $73.4K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 3/6/2024ACC: 0000950170-24-027249
Officer· SVP, Business Development
Since Mar 2026
-17.41K
Net shares
Net seller
$73.4K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
17.41K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−8.73K
Price / share
$4.30
Trade value
$37.49K
% of position
2.6%
3/4/2024
330.98K→322.25K
Common Stock
Direct
Shares
−8.68K
Price / share
$4.13
Trade value
$35.88K
% of position
2.7%
3/5/2024
322.25K→313.57K
Total
Net shares
−17.41K
Net value
-$73.38K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/4/2024 | S · Sale | −8.73K | $4.30 | $37.49K | 2.6% | 330.98K | 322.25K |
| Common Stock Direct | 3/5/2024 | S · Sale | −8.68K | $4.13 | $35.88K | 2.7% | 322.25K | 313.57K |
| Total | −17.41K | -$73.38K | ||||||
Derivative Transactions0
No derivative transactions reported